Noelle Lake, MD How might continuous IOP monitoring change glaucoma management?
David A. Goldman, MD Named one of America’s most promising companies by Forbes, Modernizing Medicine’s cloud-based system and robust ophthalmology platform continue to stand out in the EHR field.
Christopher J. Rapuano, MD Here’s a recent and welcome trend that’s part of the “long tail” of ophthalmic surgical innovation: addressing mild corneal surface abnormality before cataract surgery to optimize long-term visual outcomes.
William V. Padula, OD, SFNAP, FAAO, FNORA Eyes do more than see; ocular-vestibulomotor connections help anchor the body in space, facilitating stable imagery as well as smooth ocular and extraocular movement. Research is revealing that the ambient visual process may hold the key to helping patients maximize potentials beyond present levels of treatment following a cerebrovascular accident or brain injury.
Elizabeth Yeu, MD Devices as simple as a punctal plug may radically change and improve the way we deliver medication to patients’ eyes.
Quinton Oswald, President/CEO Neurotech Pharmaceuticals, Inc. Questions regarding the efficacy, tolerability, and best practices for long-term VEGF suppression in AMD patients continue to plague conventional bolus injection- based approaches to wet AMD treatment. A well-tolerated, implantable encapsulated cell line engineered to generate and release therapeutic molecules into the vitreous would change all that, and its advent may be closer than many think.
Harald P. Studer, PhD Biomechanical simulation of the cornea based on numerical modeling may better predict refractive outcomes than empirically generated nomograms.
Alan N. Glazier, OD, FAAO Social media will continue to change the way optometrists communicate—with each other and patients. It will also increasingly impact practice revenue, in both expected and unexpected ways.
Peter Falzon The first and only commercially available genetic test for corneal dystrophy offers a quick, affordable, and accurate way to make refractive surgery safer—and could pave the way for other genetic tests in ophthalmology.
George Cioffi, MD The means to dramatically reduce glaucoma-associated morbidity are already in our hands. The problem? We don’t always use them.